Prevalence and Effects of Cigarette Smoking, Cannabis Consumption, and Co-use in Adults From 15 Countries With Congenital Heart Disease

APPROACH-IS consortium and the International Society for Adult Congenital Heart Disease (ISACHD)

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: The prevalence and effects of cigarette smoking and cannabis use in persons with congenital heart disease (CHD) are poorly understood. We (1) described the prevalence of cigarette smoking, cannabis consumption, and co-use in adults with CHD; (2) investigated intercountry differences; (3) tested the relative effects on physical functioning, mental health, and quality of life (QOL); and (4) quantified the differential effect of cigarette smoking, cannabis use, or co-use on those outcomes. Methods: APPROACH-IS was a cross-sectional study, including 4028 adults with CHD from 15 countries. Patients completed questionnaires to measure physical functioning, mental health, and QOL. Smoking status and cannabis use were assessed by means of the Health Behaviour Scale—Congenital Heart Disease. Linear models with doubly robust estimations were computed after groups were balanced with the use of propensity weighting. Results: Overall, 14% of men and 11% of women smoked cigarettes only; 8% of men and 4% of women consumed cannabis only; and 4% of men and 1% of women used both substances. Large intercountry variations were observed, with Switzerland having the highest prevalence for smoking cigarettes (24% of men, 19% of women) and Canada the highest for cannabis use (19% of men, 4% of women). Cigarette smoking had a small negative effect on patient-reported outcomes, and the effect of cannabis was negligible. The effect of co-use was more prominent, with a moderate negative effect on mental health. Conclusions: We found significant intercountry variability in cigarette and cannabis use in adults with CHD. Co-use has the most detrimental effects on patient-reported outcomes.

Original languageEnglish (US)
Pages (from-to)1842-1850
Number of pages9
JournalCanadian Journal of Cardiology
Volume35
Issue number12
DOIs
StatePublished - Dec 2019

Fingerprint

Cannabis
Heart Diseases
Smoking
Mental Health
Tobacco Products
Marijuana Smoking
Quality of Life
Health Behavior
Switzerland
Canada
Linear Models
Cross-Sectional Studies

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Prevalence and Effects of Cigarette Smoking, Cannabis Consumption, and Co-use in Adults From 15 Countries With Congenital Heart Disease. / APPROACH-IS consortium and the International Society for Adult Congenital Heart Disease (ISACHD).

In: Canadian Journal of Cardiology, Vol. 35, No. 12, 12.2019, p. 1842-1850.

Research output: Contribution to journalArticle

APPROACH-IS consortium and the International Society for Adult Congenital Heart Disease (ISACHD) 2019, 'Prevalence and Effects of Cigarette Smoking, Cannabis Consumption, and Co-use in Adults From 15 Countries With Congenital Heart Disease', Canadian Journal of Cardiology, vol. 35, no. 12, pp. 1842-1850. https://doi.org/10.1016/j.cjca.2019.07.635
APPROACH-IS consortium and the International Society for Adult Congenital Heart Disease (ISACHD). / Prevalence and Effects of Cigarette Smoking, Cannabis Consumption, and Co-use in Adults From 15 Countries With Congenital Heart Disease. In: Canadian Journal of Cardiology. 2019 ; Vol. 35, No. 12. pp. 1842-1850.
@article{b4de797c5a034d22845c9a3dbadb8d17,
title = "Prevalence and Effects of Cigarette Smoking, Cannabis Consumption, and Co-use in Adults From 15 Countries With Congenital Heart Disease",
abstract = "Background: The prevalence and effects of cigarette smoking and cannabis use in persons with congenital heart disease (CHD) are poorly understood. We (1) described the prevalence of cigarette smoking, cannabis consumption, and co-use in adults with CHD; (2) investigated intercountry differences; (3) tested the relative effects on physical functioning, mental health, and quality of life (QOL); and (4) quantified the differential effect of cigarette smoking, cannabis use, or co-use on those outcomes. Methods: APPROACH-IS was a cross-sectional study, including 4028 adults with CHD from 15 countries. Patients completed questionnaires to measure physical functioning, mental health, and QOL. Smoking status and cannabis use were assessed by means of the Health Behaviour Scale—Congenital Heart Disease. Linear models with doubly robust estimations were computed after groups were balanced with the use of propensity weighting. Results: Overall, 14{\%} of men and 11{\%} of women smoked cigarettes only; 8{\%} of men and 4{\%} of women consumed cannabis only; and 4{\%} of men and 1{\%} of women used both substances. Large intercountry variations were observed, with Switzerland having the highest prevalence for smoking cigarettes (24{\%} of men, 19{\%} of women) and Canada the highest for cannabis use (19{\%} of men, 4{\%} of women). Cigarette smoking had a small negative effect on patient-reported outcomes, and the effect of cannabis was negligible. The effect of co-use was more prominent, with a moderate negative effect on mental health. Conclusions: We found significant intercountry variability in cigarette and cannabis use in adults with CHD. Co-use has the most detrimental effects on patient-reported outcomes.",
author = "{APPROACH-IS consortium and the International Society for Adult Congenital Heart Disease (ISACHD)} and Philip Moons and Koen Luyckx and Kovacs, {Adrienne H.} and Holbein, {Christina E.} and Corina Thomet and Werner Budts and Junko Enomoto and Sluman, {Maayke A.} and Yang, {Hsiao Ling} and Jackson, {Jamie L.} and Paul Khairy and Cook, {Stephen C.} and Shanthi Chidambarathanu and Luis Alday and Katrine Eriksen and Mikael Dellborg and Malin Berghammer and Bengt Johansson and Mackie, {Andrew S.} and Samuel Menahem and Maryanne Caruana and Gruschen Veldtman and Alexandra Soufi and Fernandes, {Susan M.} and Kamila White and Edward Callus and Shelby Kutty and Silke Apers",
year = "2019",
month = "12",
doi = "10.1016/j.cjca.2019.07.635",
language = "English (US)",
volume = "35",
pages = "1842--1850",
journal = "Canadian Journal of Cardiology",
issn = "0828-282X",
publisher = "Pulsus Group Inc.",
number = "12",

}

TY - JOUR

T1 - Prevalence and Effects of Cigarette Smoking, Cannabis Consumption, and Co-use in Adults From 15 Countries With Congenital Heart Disease

AU - APPROACH-IS consortium and the International Society for Adult Congenital Heart Disease (ISACHD)

AU - Moons, Philip

AU - Luyckx, Koen

AU - Kovacs, Adrienne H.

AU - Holbein, Christina E.

AU - Thomet, Corina

AU - Budts, Werner

AU - Enomoto, Junko

AU - Sluman, Maayke A.

AU - Yang, Hsiao Ling

AU - Jackson, Jamie L.

AU - Khairy, Paul

AU - Cook, Stephen C.

AU - Chidambarathanu, Shanthi

AU - Alday, Luis

AU - Eriksen, Katrine

AU - Dellborg, Mikael

AU - Berghammer, Malin

AU - Johansson, Bengt

AU - Mackie, Andrew S.

AU - Menahem, Samuel

AU - Caruana, Maryanne

AU - Veldtman, Gruschen

AU - Soufi, Alexandra

AU - Fernandes, Susan M.

AU - White, Kamila

AU - Callus, Edward

AU - Kutty, Shelby

AU - Apers, Silke

PY - 2019/12

Y1 - 2019/12

N2 - Background: The prevalence and effects of cigarette smoking and cannabis use in persons with congenital heart disease (CHD) are poorly understood. We (1) described the prevalence of cigarette smoking, cannabis consumption, and co-use in adults with CHD; (2) investigated intercountry differences; (3) tested the relative effects on physical functioning, mental health, and quality of life (QOL); and (4) quantified the differential effect of cigarette smoking, cannabis use, or co-use on those outcomes. Methods: APPROACH-IS was a cross-sectional study, including 4028 adults with CHD from 15 countries. Patients completed questionnaires to measure physical functioning, mental health, and QOL. Smoking status and cannabis use were assessed by means of the Health Behaviour Scale—Congenital Heart Disease. Linear models with doubly robust estimations were computed after groups were balanced with the use of propensity weighting. Results: Overall, 14% of men and 11% of women smoked cigarettes only; 8% of men and 4% of women consumed cannabis only; and 4% of men and 1% of women used both substances. Large intercountry variations were observed, with Switzerland having the highest prevalence for smoking cigarettes (24% of men, 19% of women) and Canada the highest for cannabis use (19% of men, 4% of women). Cigarette smoking had a small negative effect on patient-reported outcomes, and the effect of cannabis was negligible. The effect of co-use was more prominent, with a moderate negative effect on mental health. Conclusions: We found significant intercountry variability in cigarette and cannabis use in adults with CHD. Co-use has the most detrimental effects on patient-reported outcomes.

AB - Background: The prevalence and effects of cigarette smoking and cannabis use in persons with congenital heart disease (CHD) are poorly understood. We (1) described the prevalence of cigarette smoking, cannabis consumption, and co-use in adults with CHD; (2) investigated intercountry differences; (3) tested the relative effects on physical functioning, mental health, and quality of life (QOL); and (4) quantified the differential effect of cigarette smoking, cannabis use, or co-use on those outcomes. Methods: APPROACH-IS was a cross-sectional study, including 4028 adults with CHD from 15 countries. Patients completed questionnaires to measure physical functioning, mental health, and QOL. Smoking status and cannabis use were assessed by means of the Health Behaviour Scale—Congenital Heart Disease. Linear models with doubly robust estimations were computed after groups were balanced with the use of propensity weighting. Results: Overall, 14% of men and 11% of women smoked cigarettes only; 8% of men and 4% of women consumed cannabis only; and 4% of men and 1% of women used both substances. Large intercountry variations were observed, with Switzerland having the highest prevalence for smoking cigarettes (24% of men, 19% of women) and Canada the highest for cannabis use (19% of men, 4% of women). Cigarette smoking had a small negative effect on patient-reported outcomes, and the effect of cannabis was negligible. The effect of co-use was more prominent, with a moderate negative effect on mental health. Conclusions: We found significant intercountry variability in cigarette and cannabis use in adults with CHD. Co-use has the most detrimental effects on patient-reported outcomes.

UR - http://www.scopus.com/inward/record.url?scp=85075917363&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85075917363&partnerID=8YFLogxK

U2 - 10.1016/j.cjca.2019.07.635

DO - 10.1016/j.cjca.2019.07.635

M3 - Article

C2 - 31813510

AN - SCOPUS:85075917363

VL - 35

SP - 1842

EP - 1850

JO - Canadian Journal of Cardiology

JF - Canadian Journal of Cardiology

SN - 0828-282X

IS - 12

ER -